Media 2021
…Hudson Institute of Medical Research Associate Professor Michael Gantier BusinessWire Street Insider Daily Herald Chicago Biopharma Reporter November New hope in lung cancer war Dr Daniel Gough Herald Sun Hobart…… Read more
…Hudson Institute of Medical Research Associate Professor Michael Gantier BusinessWire Street Insider Daily Herald Chicago Biopharma Reporter November New hope in lung cancer war Dr Daniel Gough Herald Sun Hobart…… Read more
…deaths a day Dr Michael Gantier Herald Sun Young swept up in new virus wave Dr Michael Gantier Herald Sun Securing Future Of Regenerative Medicine In Victoria Mirage News Backing…… Read more
…Associate Professor Michael Gantier has established that idronoxil, which was originally designed to treat cancers, could reduce the inflammation that occurs in response to COVID-19. The research is published in…… Read more
…disease Sickle cell disease Chronic obstructive pulmonary disease Inflammatory bowel disease (IBD) Non-alcoholic steatohepatitis (NASH) Pneumonia Type 2 diabetes Soy anti-inflammatory effects Associate Professor Michael Gantier, whose work has recently…… Read more
…that a century-old antiseptic called Acriflavine, made from coal tar, protects against the common cold. The findings of the study, led by Dr Michael Gantier and Dr Genevieve Pepin in…… Read more
…researchers Associate Professor Seth Masters and Dr Alan Yu, with colleagues from the University of Melbourne and Hudson Institute of Medical Research scientist Dr Michael Gantier. Co-author of the study…… Read more
…journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College of Surgeons in Ireland, University…… Read more
Media 2022 December Noxopharm autoimmune treatment pipeline bolstered with $1.5 million grant to medical research partner Associate Professor Michael Gantier Proactive Investors BiomeBank has raised $10.7m to fast-track its treatments…… Read more
…Samuel Forster Microbiota and Systems Biology Antimicrobial resistance, COVID-19, Gastroenteritis, Inflammatory bowel disease (IBD), Microbiome in health and disease Associate Professor Michael Gantier Nucleic Acids and Innate Immunity COVID-19, Inflammation…… Read more
…and rolled out. We’ve only scratched the surface of the potential applications of RNA therapies.”- Associate Professor Michael Gantier “RNA therapeutics is the technology of the decade,” said A/Prof Gantier….… Read more